drugset / Trial / NCT04767620
Clinical Trial of Ruxian Zengsheng No. 1 Decoction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A prospective, open, randomized, controlled phase II clinical study is planned to clarify the efficacy and related adverse reactions of Mammary Glandular Hyperplasia No. 1 Decoction in the treatment of liver-qi stagnation type breast hyperplasia, relieve the pain of patients with breast hyperplasia, and improve the quality of life of patients.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rugdenzengsheng No. 1 prescription | Traditional medicine (herbal / TCM) | — | Oral |